Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SYNTHETECH - NZYM -- Ignore unavailable to you. Want to Upgrade?

To: Dan Gibbs who wrote (327)	5/11/2000 3:01:00 AM
From: tuck	Read Replies (1) \| Respond to of 372

Dan, Perhaps I should have been more specific. It was the following sentence that caught my eye: "Nevertheless, in the longer term, some of the innovative antisense technologies such as locked nucleic acid (LNA) and peptide nucleic acid (PNA) have good prospects." It could be that just because the word peptide is involved, doesn't neccesarily mean that makers of PNAs will be buying NYZM's products. PNAs, too, look more like nucleic acids than peptides? I'm not biochemist enough to know. I appreciate your help. Cheers, Tuck